Hayward, CA, United States of America

Zyomyx, Incorporated


USPTO Granted Patents = 27

% Expired Patents = 48.1


Forward Citations = 1,729

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Peter K Wagner (26 out of 34 patents)

silverMedal Steffen Nock (17 out of 18 patents)

bronzeMedal Dana Ault-Riche (11 out of 11 patents)

4.  Christian Itin (11 out of 11 patents)

5.  Frank G Zaugg (9 out of 16 patents)

6.  Pierre F Indermuhle (7 out of 51 patents)

7.  Peter Kernen (5 out of 7 patents)

8.  Paul Jedrzejewski (4 out of 4 patents)

9.  Renee Tobias (3 out of 3 patents)

10.  Silvia McManus-Munoz (3 out of 3 patents)

11.  Laurence Ruiz-Taylor (3 out of 4 patents)

12.  Hongbo Lu (2 out of 2 patents)

13.  Huu Minh Tran (2 out of 9 patents)

14.  Mark Andrew Scalf (1 out of 6 patents)

15.  Nock Steffen (1 out of 1 patent)


Core Competencies:
Cell Assay Kit
Microfluidic Devices
Ion Detection
Bioconjugation
Impedance Spectroscopy
Protein Arrays
High-Throughput Screening
Biomolecule Screening
Non-Specific Binding
Fluid Characteristic Detection
Protein-Capture Agents
Microdevices

27 patents:

Zyomyx, Incorporated is a biotechnology company based in Hayward, California, specializing in the development of advanced diagnostic and therapeutic solutions. The organization focuses on innovative technologies that enhance the detection and analysis of biological molecules, aiming to improve healthcare outcomes. Zyomyx's expertise spans various domains, including biomarker discovery and assay development, positioning it as a key player in the life sciences sector, dedicated to addressing critical challenges in diagnostics and personalized medicine.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

27 Patents

#27 in Hayward, CA

#2,931 in California

#12,405 in US

#23,968 in the World

Hayward, CA (US)
Hayward, CA, United States of America
Forward Citations = 1,729

20 inventors:

Please report any incorrect information to [email protected]
Loading…